Related Experiment Videos
Osteoarticular complications in bismuth encephalopathy
Clinical Toxicology
|November 1, 1981
Summary
Bismuth encephalopathy can cause severe osteoarticular lesions, particularly in female patients, affecting the spine and humerus. These bone issues, including fractures and osteonecrosis, are linked to severe neurological symptoms.
Area of Science:
- Neurology
- Orthopedics
- Toxicology
Background:
- Bismuth encephalopathy is a neurological disorder associated with bismuth exposure.
- Osteoarticular manifestations are not commonly recognized complications of bismuth toxicity.
- Previous studies have not extensively documented the skeletal effects of bismuth encephalopathy.
Purpose of the Study:
- To investigate the occurrence and characteristics of osteoarticular lesions in patients with bismuth encephalopathy.
- To identify specific skeletal sites and types of lesions associated with this condition.
- To explore potential mechanisms underlying bismuth-induced bone abnormalities.
Main Methods:
- Retrospective analysis of 59 cases of bismuth encephalopathy diagnosed between 1972 and 1979.
- Detailed examination of clinical records and radiological findings for osteoarticular abnormalities.
- Focus on a subgroup of eight female patients exhibiting specific skeletal lesions.
Main Results:
- Eight female patients presented with osteoarticular lesions exclusively in the thoracic vertebrae and humerus.
- Lesions included humeral neck fractures (6 cases), spine fractures (3 cases), and humeral head osteonecrosis (5 cases).
- Skeletal abnormalities were more prevalent in severe, chronic myoclonic, and convulsive forms of bismuth encephalopathy.
Conclusions:
- Bismuth encephalopathy can lead to significant osteoarticular lesions, particularly affecting the thoracic spine and humerus in female patients.
- Intraspongy microfractures from intense myoclonus may contribute to osteonecrosis.
- While bismuth's role in bone tissue modification is suggested, conclusive evidence is limited due to minimal phosphocalcic metabolism anomalies.